Published in Law and Health Weekly, January 8th, 2005
The financing is structured to support the prospective acquisition of certain biotechnology assets and intellectual property that the company is currently pursuing.
The equity private placement was made by Mercator Advisory Group, LLC of Los Angeles, California, through its designated funds, Mercator Momentum Fund, LP. and Mercator Momentum Fund III, LP.
Ascendiant Securities LLC of Irvine, California served as placement agent on the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.